×




Indonesia's Pharmaceutical Industry in 1998 Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Indonesia's Pharmaceutical Industry in 1998 case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Indonesia's Pharmaceutical Industry in 1998 case study is a Harvard Business School (HBR) case study written by Carin-Isabel Knoop, Anthony St. George. The Indonesia's Pharmaceutical Industry in 1998 (referred as “Indonesian Pharmaceutical” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, Recession.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Indonesia's Pharmaceutical Industry in 1998 Case Study


This case describes the Indonesian pharmaceutical market in 1997 and the impact on the market of the Indonesian rupiah's 75% devaluation since July 1997. Major foreign and domestic players are described. It raises the issue of how the Indonesian pharmaceutical market might change as a result of the crisis and whether the balance of power between local and global players has shifted. In the pharmaceutical industry, the Asian market--including Southeast Asia, Japan, China, Korea, and India--constituted one-third of global revenues and had experienced above average growth.


Case Authors : Carin-Isabel Knoop, Anthony St. George

Topic : Strategy & Execution

Related Areas : Recession




Calculating Net Present Value (NPV) at 6% for Indonesia's Pharmaceutical Industry in 1998 Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10028440) -10028440 - -
Year 1 3448008 -6580432 3448008 0.9434 3252838
Year 2 3982246 -2598186 7430254 0.89 3544185
Year 3 3973488 1375302 11403742 0.8396 3336217
Year 4 3247560 4622862 14651302 0.7921 2572372
TOTAL 14651302 12705611




The Net Present Value at 6% discount rate is 2677171

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Internal Rate of Return
3. Payback Period
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Indonesian Pharmaceutical shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Indonesian Pharmaceutical have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Indonesia's Pharmaceutical Industry in 1998

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Indonesian Pharmaceutical often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Indonesian Pharmaceutical needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10028440) -10028440 - -
Year 1 3448008 -6580432 3448008 0.8696 2998268
Year 2 3982246 -2598186 7430254 0.7561 3011150
Year 3 3973488 1375302 11403742 0.6575 2612633
Year 4 3247560 4622862 14651302 0.5718 1856803
TOTAL 10478854


The Net NPV after 4 years is 450414

(10478854 - 10028440 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10028440) -10028440 - -
Year 1 3448008 -6580432 3448008 0.8333 2873340
Year 2 3982246 -2598186 7430254 0.6944 2765449
Year 3 3973488 1375302 11403742 0.5787 2299472
Year 4 3247560 4622862 14651302 0.4823 1566146
TOTAL 9504407


The Net NPV after 4 years is -524033

At 20% discount rate the NPV is negative (9504407 - 10028440 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Indonesian Pharmaceutical to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Indonesian Pharmaceutical has a NPV value higher than Zero then finance managers at Indonesian Pharmaceutical can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Indonesian Pharmaceutical, then the stock price of the Indonesian Pharmaceutical should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Indonesian Pharmaceutical should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What can impact the cash flow of the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Understanding of risks involved in the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What will be a multi year spillover effect of various taxation regulations.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Indonesia's Pharmaceutical Industry in 1998

References & Further Readings

Carin-Isabel Knoop, Anthony St. George (2018), "Indonesia's Pharmaceutical Industry in 1998 Harvard Business Review Case Study. Published by HBR Publications.


Natori Co Ltd SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


G1 Therapeutics SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


HM Intl SWOT Analysis / TOWS Matrix

Services , Printing Services


Harima Chemicals Group SWOT Analysis / TOWS Matrix

Basic Materials , Chemicals - Plastics & Rubber


SAP ADR SWOT Analysis / TOWS Matrix

Technology , Software & Programming


InnoTek Ltd SWOT Analysis / TOWS Matrix

Consumer Cyclical , Appliance & Tool